Protective efficacy of a novel hepatitis B vaccine consisting of M (pre-S2 + S) protein particles (a third generation vaccine)
- 1 June 1990
- Vol. 8 (3) , 192-198
- https://doi.org/10.1016/0264-410x(90)90044-m
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Immunogenicity of a new type of yeast-derived hepatitis B vaccine consisting of M (pre-S2 + S) protein particlesVaccine, 1989
- TRANSMISSION OF HEPATITIS B FROM HEPATITIS-B-SERONEGATIVE SUBJECTSThe Lancet, 1988
- Recombinant hepatitis B virus surface antigen carrying the pre-S2 region derived from yeast: purification and characterizationJournal of Biotechnology, 1988
- Hepatitis B vaccines--to switch or not to switchPublished by American Medical Association (AMA) ,1987
- Synthesis in yeast of hepatitis B virus surface antigen modified P31 particles by gene modificationBiochemical and Biophysical Research Communications, 1986
- Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virusCell, 1986
- Antibodies to a synthetic peptide from the preS 120–145 region of the hepatitis B virus envelope are virus-neutralizingVaccine, 1986
- Clinical evaluation in healthy adults of a hepatitis B vaccine made by recombinant DNAPublished by American Medical Association (AMA) ,1984
- Synthesis and assembly of hepatitis B virus surface antigen particles in yeastNature, 1982
- Nucleotide sequence of the gene coding for the major protein of hepatitis B virus surface antigenNature, 1979